Cardiovascular events after liver transplantation: MACE hurts

The curative therapy for patients with end-stage liver disease is liver transplantation. However, liver transplantation challenges the cardiovascular system, and is associated with major adverse cardiovascular events (MACE). Immediately after implantation of the liver graft, changes in cardiac prelo...

Full description

Saved in:
Bibliographic Details
Published in:Reviews in cardiovascular medicine 2022-03, Vol.23 (3), p.91-91
Main Authors: Altieri, Mario H, Liu, Hongqun, Lee, Samuel S
Format: Article
Language:English
Subjects:
arrhythmias
Cardiomyopathies - diagnosis
cardiovascular complications
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - etiology
cirrhotic cardiomyopathy
End Stage Liver Disease - complications
End Stage Liver Disease - surgery
Heart
heart failure
Heart Failure - etiology
Humans
liver transplantation
Liver Transplantation - adverse effects
Risk Factors
ventricular dysfunction
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The curative therapy for patients with end-stage liver disease is liver transplantation. However, liver transplantation challenges the cardiovascular system, and is associated with major adverse cardiovascular events (MACE). Immediately after implantation of the liver graft, changes in cardiac preload and afterload increase the cardiac workload. Longer-term postoperatively, a more sedentary lifestyle and enhanced appetite increase obesity and body mass index. Immunosuppressants may also affect the cardiovascular system. All these factors that liver recipients encounter impact the function of the cardiovascular system. Cardiac events are the third-leading cause of death in liver recipients. This review describes the pertinent factors that predispose to development of MACE after liver transplantation, and how to predict these cardiovascular events in the post-transplant period. We review the roles of metabolic syndrome, renal dysfunction, non-alcoholic fatty liver disease, diagnostic tests such as imaging and biomarkers, and parameters such as systolic and diastolic dysfunction, and QT interval prolongation in cardiovascular events. We summarize the current literature on scoring systems to predict cardiovascular events.
ISSN:1530-6550
DOI:10.31083/j.rcm2303091